SB
LLY icon

Strategic Blueprint’s Eli Lilly LLY Stock Holding History

Strategic Blueprint’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,200
Closed -$935K – 748
2025
Q2 		$935K Buy
+1,200
New +$932K 0.05% 308

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Strategic Blueprint's LLY Position: Q2 2026 in Review

Strategic Blueprint increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $1.46M and bringing the position to 13,696 shares worth $16.4M. The position accounts for 0.82% of the portfolio, ranked #22.

Strategic Blueprint first reported a position in LLY in Q2 2020 and has held it in 25 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strategic Blueprint held 13,696 shares of Eli Lilly worth $16.4M as of Q2 2026.
  • Strategic Blueprint bought 1,430 Eli Lilly shares in Q2 2026, an estimated $1.46M.
  • Eli Lilly made up 0.82% of Strategic Blueprint's portfolio in Q2 2026, its #22 holding.
  • Strategic Blueprint first reported a position in Eli Lilly in Q2 2020 and has held it in 25 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.